PREPARATION OF ANTI-CTLA-4 ANTIBODY AND FUSION PROTEIN - SHANGHAI CELGEN BIO PHARMACEUTICAL CO LTD

Title:

PREPARATION OF ANTI-CTLA-4 ANTIBODY AND FUSION PROTEIN

Document Type and Number:

WIPO Patent Application WO/2022/122034

Kind Code:

A1

Abstract:

The present invention provides an anti-CTLA-4 antibody composition, the composition comprising an anti-CTLA-4 monoclonal antibody, a surfactant, a buffer and a stabilizer. The composition of the present invention can improve the stability of anti-CTLA-4 antibodies.

More Like This:

WO/2018/103119	HYDROBROMATE OF BENZODIAZEPINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF
JP2022539077	PEGylated cystathionine beta synthase for enzymatic therapy to treat homocystinuria
WO/2017/147318	COMPOSITIONS AND METHODS FOR MAKING AND USING THERMOSTABLE IMMUNOGENIC FORMULATIONS WITH INCREASED COMPATIBILITY OF USE AS VACCINES AGAINST ONE OR MORE PATHOGENS

Inventors:

FANG GUOBO (CN)
CAI ZELING (CN)
WU HENG (CN)

Application Number:

PCT/CN2021/137235

Publication Date:

June 16, 2022

Filing Date:

December 10, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SHANGHAI CELGEN BIO PHARMACEUTICAL CO LTD (CN)

International Classes:

A61K9/19; A61K9/08; A61K39/395; A61K47/02; A61K47/10; A61K47/12; A61K47/14; A61K47/18; A61K47/26; A61K47/44; A61P35/00; A61P37/02; C07K16/00

Foreign References:

CN110840830A	2020-02-28
CN112569183A	2021-03-30
CN101325968A	2008-12-17
CN103861102A	2014-06-18
CN106390115A	2017-02-15
CN111655728A	2020-09-11

Attorney, Agent or Firm:

XU&PARTNERS, LLC. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: LITHIUM ION BATTERY

Next Patent: COAGULATION FACTOR XIA INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF